BUSINESS REGISTRATION NUMBER
BRN 67233226

Live

Filorga International Medical Group Co., Limited

菲洛嘉醫學國際集團有限公司

Registry Verified: 2020-03-20

Jurisdiction: Hong Kong, China

Filorga International Medical Group Co., Limited (菲洛嘉醫學國際集團有限公司) is a Hong Kong corporation duly incorporated under the Companies Ordinance (Cap. 622), legally classified as a Private company limited by shares. Its official Company Registration Number (CR No. / CRN) is 2483550, and Business Registration Number (BRN) is 67233226. Incorporated on 2017-02-09, the entity has maintained continuous statutory operations for 9 years and 9 months, currently holding an active legal status of Live. The registered office is situated at ROOM B3, 3/F, TAI TAK INDUSTRIAL BUILDING, 2-12 KWAI FAT ROAD, KWAI CHUNG, NEW TERRITORIES, HONG KONG. Regarding statutory filings, pursuant to Section 662 of the Companies Ordinance (Cap. 622), its annual return filing window falls between Feb 09 – Mar 23 (within 42 days after its incorporation anniversary), with the latest Annual Return (Form NAR1) officially filed on 2020-03-20; a total of 7 statutory filings (spanning 2017–2020, latest filed on 2020-03-20) are indexed in the registry, comprising 3 Annual Return(s) (NAR1), 1 officer/secretary change notice(s) (ND2A).

I. Corporate Profile & Statutory Registry Records

Official Chinese Name	菲洛嘉醫學國際集團有限公司	Official English Name	Filorga International Medical Group Co., Limited
Company Reg No. (CRN)	2483550	Business Reg No. (BRN)	67233226
Incorporation Date	2017-02-09	Company Category	Private company limited by shares
Current Legal Status	Live	Statutory Filing Cycle	2026-02-09

Registered Office Address	ROOM B3, 3/F, TAI TAK INDUSTRIAL BUILDING, 2-12 KWAI FAT ROAD, KWAI CHUNG, NEW TERRITORIES, HONG KONGTai Tak Industrial Building · View Co-Located Entities →
Significant Controllers (SCR)	Statutorily maintained. To penetrate ultimate beneficial owners (UBO) and holding structures, please apply for a Due Diligence Report.

#	Filing Date	Document No.	Document Name	Pages	Tariff
1	2020-03-20	22401880456	NAR1 Annual Return (2020)Latest Shareholders & Directors	8	HK$ 28
2	2019-05-31	22000913769	ND2A Notice of Change of Company Secretary and Director	4	HK$ 20
3	2019-02-28	22601878072	NAR1 Annual Return (2019)	9	HK$ 28
4	2018-03-20	23301364390	NAR1 Annual Return (2018)	9	HK$ 28
5	2017-02-09	23301252705	NNC1 Incorporation Form (Company Limited by Shares)	8	HK$ 28
6	2017-02-09	40011415691	CI Certificate of Incorporation (CI)	1	HK$ 20
7	2017-02-09	23301252706	A&A Articles of Association (A&A)	9	HK$ 33

III. Commercial Due Diligence & Regulatory Risk Screening

Cross-screened across 32 HK statutory regulators, court dockets & sanctions registers: 0 licences, 0 public litigation/HCCW records, 0 sanctions hits.

IV. Corporate Statutory Dossier & Legal Status FAQ

What is the official statutory registration status of Filorga International Medical Group Co., Limited in Hong Kong?

Yes. Filorga International Medical Group Co., Limited is a legitimate Hong Kong corporation (Private company limited by shares) duly incorporated under the Companies Ordinance (Cap. 622) on 2017-02-09 (operating for 9 years). According to official registers of the Hong Kong Companies Registry (CR), the entity holds an active statutory standing of [Live / In Operation], possessing independent legal personality and full corporate capacity (Statutory verification: March 2020).

How to verify the Unique Business Identifier (UBI / BRN) and CRN of Filorga International Medical Group Co., Limited?

The statutory primary identifiers for Filorga International Medical Group Co., Limited are: 1. Business Registration Number (BRN / Unique Business Identifier UBI): [67233226] (effective from 27 December 2023, this 8-digit number issued under Cap. 310 serves as the unified cross-departmental corporate identifier); 2. Company Registration Number (CRN): [2483550] (incorporation archive number issued under Cap. 622). Together, these dual keys uniquely lock the entity in international banking KYC and cross-border contracts.

How to verify the Register of Directors, shareholder equity ratios, and Significant Controllers (SCR) of Filorga International Medical Group Co., Limited?

Under the Companies Ordinance (Cap. 622) of Hong Kong, incorporated companies do not maintain a single 'legal representative' position; the Board of Directors (Section 643) exercises statutory management authority. Complete current and historical directorships (Form ND2A), registered member shareholdings (Form NAR1 / Section 627), and Ultimate Beneficial Ownership (UBO / SCR under Part 12 Division 2A) are verified through official statutory filing retrieval.

How to retrieve the certified company registry filings and Form NAR1 of Filorga International Medical Group Co., Limited?

Yes. Statutory indexing confirms that Filorga International Medical Group Co., Limited has accumulated 7 official filing dossier(s) archived in the Hong Kong Companies Registry (latest statutory filing indexed on 2020-03-20: Form NAR1 - Annual Return (2020)). Pursuant to Section 662 of the Companies Ordinance (Cap. 622), private companies must deliver an Annual Return (Form NAR1) within 42 days after each incorporation anniversary. Available barcoded dossiers include: latest Annual Return (Form NAR1 - detailing current share capital, registered office, directors, and member shareholdings), Incorporation Form (Form NNC1), Articles of Association, and Change of Company Secretary and Director notices (Form ND2A), each bearing authentic ICRIS electronic barcode verification.

What is the official registered address of Filorga International Medical Group Co., Limited for legal service of process?

The statutory registered office of Filorga International Medical Group Co., Limited on official record is situated at: [ROOM B3, 3/F, TAI TAK INDUSTRIAL BUILDING, 2-12 KWAI FAT ROAD, KWAI CHUNG, NEW TERRITORIES, HONG KONG]. Pursuant to Section 658 of the Companies Ordinance (Cap. 622), every Hong Kong company must maintain a registered office in Hong Kong to which all communications and legal notices may be addressed, and file Form NR1 within 15 days of any address change.